Enhancing the activity of Amycolatopsis orientalis, a producer of antibiotic eremomycin, and study of its antibacterial action

The widespread use of antibiotics in agriculture is associated with emerging challenges, which underscores the relevance of searching for and developing effective antimicrobial agents. The aim of this work was to obtain a new highly productive strain producing the glycopeptide antibiotic eremomycin and to evaluate the antibacterial activity of a partially purified preparation isolated from the culture liquid of the obtained strain. A new strain – Amycolatopsis orientalis E 27-22 – was obtained through a combination of multistage selection and non-targeted ultraviolet mutagenesis. A simplified isolation of eremomycin was carried out by single-step sorption from the culture filtrate onto a macroporous resin. The antibacterial activity against a number of gram-positive test cultures (Staphylococcus aureus, Staphylococcus epidermidis, Micrococcus luteus, Bacillus subtilis, Clostridium perfringens) was evaluated using agar diffusion and minimum inhibitory concentration determination methods, in comparison with commercial vancomycin and highly purified eremomycin. The productivity of the new strain ranged 4.51±0.23 g/L, which is 31.87% higher than that of the parent strain Amycolatopsis orientalis VKM Ac-2717D. The eremomycin content in the partially purified preparation reached 70.0 ± 2.0 wt%. Despite the simplified isolation technology, the obtained preparation was shown to retain high biological activity, being no more than twofold less active than the reference antibiotics, and comparable to vancomycin against Micrococcus luteus and Clostridium perfringens. The results obtained confirm the feasibility of further development of a simplified isolation process for potential application in agriculture.

1. Panditharathne P.N.K.W., Kumbukgolla W.W., Jayaweera J.A.A.S., Rawat D.S. Review on usage of vancomycin in livestock and humans: maintaining its efficacy, prevention of resistance and alternative therapy. Veterinary Sciences. 2017;4(1):6. DOI: 10.3390/vetsci4010006.

2. Mann А., Nehra К., Rana J.S, Dahiya T. Antibiotic resistance in agriculture: perspectives on upcoming strategies to overcome upsurge in resistance. Current Research in Microbial Sciences. 2021;2:100030. DOI: 10.1016/j.crmicr.2021.100030.

3. Sazykin I.S., Khmelevtsova L.E., Seliverstova E.Y., Sazykina M.A. Effect of antibiotics used in animal husbandry on the distribution of bacterial drug resistance (review). Applied Biochemistry and Microbiology. 2021;57(1):20-30. DOI: 10.1134/S0003683821010166.

4. Low C.X., Tan L.T.-H., Mutalib N.-S.A., Pusparajah P., Letchumanan V., Lee L.-H., et al. Unveiling the impact of antibiotics and alternative methods for animal husbandry: a review. Antibiotics. 2021;10(5):578. DOI: 10.3390/antibiotics10050578.

5. Samarin G.N., Belyakov M.V., Lyashchuk Yu.O. Current trends in the use of antimicrobials in agriculture. Russian Journal of Resources, Conservation and Recycling. 2023;10(1):20. (In Russian). DOI: 10.15862/22ECOR123. EDN: LONKRL.

6. Vysochanskaya O.N., Kuleshova S.I., Simonova E.P. Glycopeptide antibiotics: structural and functional aspects, application in medicine and standardization. Bulletin of the Scientific Center for Expertise of Medical devices. Regulatory Research and Expertise of medicines. 2023;13(2-1):261-270. (In Russian). DOI: 10.30895/1991-2919-2022-447.

7. Kisil O.V., Efimenko T.A., Efremenkova O.V. Looking back to Amycolatopsis: history of the antibiotic discovery and future prospects. Antibiotics. 2021;10:1254. DOI: 10.3390/antibiotics10101254.

8. Gause G.F., Brazhnikova M.G., Lomakina N.N., Berdnikova T.F., Fedorova G.B., Tokareva N.L., et al. Eremomycin-new glycopeptide antibiotic: chemical properties and structure. Journal of Antibiotics. 1989;42(12):1790-1799. DOI: 10.7164/antibiotics.42.1790.

9. Park S., Ronholm J. Staphylococcus aureus in agriculture: lessons in evolution from a multispecies pathogen. Clinical Microbiology Reviews. 2021;34(2):e00182-e00220. DOI: 10.1128/CMR.00182-20.

10. Kisil O.V., Gabrielyan N.I., Maleev V.V. Antibiotic resistance - what can be done? A review. Therapeutic Archive. 2023;95(1):90-95. (In Russian). DOI: 10.26442/00403660.2023.01.202040. EDN: CZDJLC.

11. Malkova I.V., Borisova O.K., Pavlova M.V., Zemlyanitskaya E.P., Sergeeva T.I. In vitro activity of the new glycopeptide antibiotic eremomycin against obligate anaerobic gram-positive bacteria. Antibiotics and Chemotherapy. 1991;36(4):17-20. (In Russian).

12. Ryzhkov I.O., Samsonov M.Yu., Chernobrovkin M.G., Shobolov D.L. Method for treating human diseases caused by gram-positive bacteria. Patent RF, no. 2661613; 2018. (In Russian).

13. Brazhnikova M.G., Lajko A.V., Fedorova G.B., Preobrazhenskaya T.P., Sveshnikova M.A., Lapchinskaya O.A., et al. Strain Amycolatopsis orientalis subsp. eremomycini VKPM S-892 is a producer of the antibiotic eremomycin and a method for obtaining the antibiotic eremomycin. Patent RF, no. 2110578; 1998. (In Russian).

14. Goldenberg L.E., Stepanova E.S., Vetrogradova T.P., Shevchuk L.A., Shepelevtseva N.G. Preclinical toxicological study of the new antibiotic eremomycin. Antibiotiki i biotekhnologii. 1987;32(12):910-915. (In Russian).

15. Dzhavakhiya V.V., Glagoleva E.V., Popova E.D., Ovchinnikov A.I., Skryabin K.G., Shobolov D.L., et al. Development of a new Amycolatopsis orientalis strain for high-yield eremomycin production. Biotechnology. 2017;33(1):42-52. (In Russian). DOI: 10.1016/0234-2758-2017-33-1-42-52. EDN: YNTLXT.

16. Dzhavakhiya V.V., Glagoleva E.V., Popova E.D., Ovchinnikov A.I., Skryabin K.G., Shobolov D.L., et al. Strain Amycolatopsis orientalis – producer of the antibiotic eremomycin and method for producing eremomycin. Patent RF, no. 2621866; 2017. (In Russian).

17. Bulygina E.S., Kuznetsov B.B., Marusina A.I., Kravchenko I.K., Bykova S.A., Kolganova T.V., et al. Study of nucleotide sequences of nifH genes of some methanotrophic bacteria. Microbiology. 2002;71(4):500-508. (In Russian).

18. Shakhova D., Kanochkina M.S. Prospects and features of the turbidimetric analysis method for determining the antimicrobial activity of peptides and antibiotics of the glycopeptide series (review). Health, Food & Biotechnology. 2024;6(4):73-93. (In Russian). DOI: 10.36107/hfb.2024.i4.s242. EDN: IDWVZE.

19. Gauze G.F., Preobrazhenskaja T.P., Lajko A.V., Selezneva T.I., Sveshnikova M.A., Brazhnikova M.G., et al. Antibiotic Eremomycin and method of its preparing. Patent USSR, no. 1475150; 1997. (In Russian).

20. Lapchinskaya O.A., Fedorova G.B., Pogozheva V.V., Preobrazhenskaya M.N., Katrukhha G.S., Ponomarenko V.I., et al. Strain Amycolatopsis orientalis VKPM-As-807 – producer of Eremomycin. Patent RF, no. 2352631; 2009. (In Russian).

21. Irianto V.S., Demirkan E., Cetinkaya A. A. UV-mutagenesis for lipase overproduction from Bacillus cereus ATA179, nutritional optimization, characterization and its usability in the detergent industry Preparative Biochemistry & Biotechnology. 2023;54(7):918-931. DOI: 10.1080/10826068.2023.2299441.

22. Yaderets V.V., Karpova N.V., Glagoleva E.V., Petrova K.S., Shibaeva A.S., Dzhavakhiya V.V. Carotenoids: Overview of the main methods and conditions of their preparation. Proceedings of Universities. Applied Chemistry and Biotechnology. 2024;14(1):41-54. (In Russian). DOI: 10.21285/achb.905. EDN: LQHTED.

23. Zhu Q., Han Q., Zhang S. The ultraviolet-b radiation characteristics of planar excilamps filled with gas mixture of xenon, bromine and chlorine. Plasma Chemistry and Plasma Processing. 2024;44:523-546. DOI: 10.1007/s11090-023-10428-6.

24. Stackebrandt E., Ebers J. Taxonomic parameters revisited: tarnished gold standards. Microbiology Today. 2006;8(4):152-155.

25. Bely P.A., Lopatukhin E.Yu., Zaslavskaya K.Ya., Fedorov S.V., Zemskov D.N., Nigmatova D.N. A new strain of Amycolatopsis japonica producing vancomycin. Patent RF, no. 2788348; 2023. (In Russian).

26. Shchekotikhin A.E., Moiseenko E.I., Korolev A.M., Grammatikova N.E., Mirchink E.P., Isakova E.B. New Derivatives of Eremomycin and Their Application for the Treatment of Bacterial Infections. Patent RF, no. 2708628; 2019. (In Russian).

27. Moiseenko E.I., Grammatikova N.E., Shchekotikhina A.E. Synthesis and antibacterial activity aminoalkyl - amides of eremomycin. Macroheterocycles. 2020;13(3):298-304. (In Russian). DOI: 10.6060/mhc200812s.

28. Lagun L.V., Kulvinsky Ya.A., Kulvinskaya N.A. Study of the sensitivity of methicillin-resistant Staphylococcus aureus to antibiotics and bacteriophage preparations. Health and Ecology Issues. 2024;21(1):93-101. (In Russian). DOI: 10.51523/2708-6011.2024-21-1-12. EDN: XYQPNQ.

29. Das M.C., Biswas A., Chowdhury M., Saha J. Screening antimicrobial susceptibility of gentamicin, vancomycin, azithromycin, chloramphenicol and cefotaxime against selected gram positive and gram negative bacteria. International Journal of Pharma Research and Health Sciences. 2014;2(4):324-331.

30. Pederson A., Coleman R.B., Irving M. An unknown source of Micrococcus luteus bacteremia. The Southwest Respiratory and Critical Care Chronicles. 2023;11(48):43-45. DOI: 10.12746/swrccc.v11i48.1187.

31. Szemraj M., Glajzner P., Sienkiewicz M. Decreased susceptibility to vancomycin and other mechanisms of resistance to antibiotics in Staphylococcus epidermidis as a therapeutic problem in hospital treatment. Scientific Reports. 2023;13(1):13629. DOI: 10.1038/s41598-023-40866-3.

32. Álvarez-Pérez S., Anega B., Blanco J.L., Hernández M., García M.E. In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats. BMC Veterinary Research. 2023;19(1):238. DOI: 10.1186/s12917-023-03801-2.